NEWS

Montagu announced today its intention to create a world-leading medical devices supplier by supporting the merger of Tyber Medical, Intech and Resolve Surgical Technologies (“Resolve”). As part of the transaction, Montagu entered into a definitive agreement to acquire Tyber Medical, an innovative medical device company providing private label development and manufacturing … [Read more...] about Tyber Medical, Intech and Resolve Surgical Technologies combine to form a next-generation solutions provider to the Medical Device industry

Thank you, Centinel Spine! On behalf of the SPINEMarketGroup team, we sincerely appreciate your continued support as a PLATINUM sponsor for 2025.We are very proud to continue this journey together for another year! About Centinel Spine, LLC Centinel Spine®, LLC is the leading global medical device company addressing cervical and lumbar spinal disease with the most … [Read more...] about We are proud to announce that Centinel Spine will once again sponsor SPINEMarketGroup in 2025!

PARIS (France) and BOULDER (CO, USA), January 10, 2025 – 6:00 pm CET  - SpineGuard (FR0011464452 – ALSGD), an innovative company that deploys its DSG® (Dynamic Surgical Guidance) local conductivity sensing technology to secure and streamline the placement of bone implants, today reports its full-year 2024 revenue. Pierre Jérôme, Chairman, CEO and co-founder … [Read more...] about SpineGuard Reports its full-year 2024 Revenue

Alachua, Fla. (January 7, 2025) – NovApproach Spine, developer of the patented OneLIFTM interbody spinal fusion system which supports a multitude of surgical approaches, announced today the appointment of spine industry executive Kris Renton as Chief Commercialization Officer. Renton will leverage more than 25 years of experience specializing in spine sales, including … [Read more...] about NovApproach Spine Names Kris Renton Chief Commercialization Officer

A recent study published in Nature by researchers at The Francis Crick Institute in London represents a significant breakthrough in embryonic research. For the first time, scientists have successfully grown a human notochord from stem cells. This crucial tissue, present during early development, serves as a guide for forming the spine and nervous system—an aspect that has been … [Read more...] about Scientists Successfully Grow Human Notochord – What This Means for the Spine Industry?

Enhancing Access to Product Information: Over 1,200 Videos Now Available: https://thespinemarketgroup.com/videos/ We’re happy to share that we’ve recently made an update to our "Videos" section. It now includes more than 1,200 videos featuring products from a variety of companies. Some of these videos are older and feature products that were part of companies acquired later … [Read more...] about Enhancing Access to Product Information: Over 1,200 Videos Now Available!

SEOUL, South Korea, Dec. 31, 2024 /PRNewswire/ -- CG MedTech (f/k/a Innosys, CEO Ju Mi Chung), a leading Korean orthopedic implant research and manufacturing company, partnered with CGBIO to host the International Spine Endoscopy Training Course. The event welcomed 12 medical professionals from nine countries, … [Read more...] about CG MedTech and CGBIO Showcase Korea’s Spine Surgery Excellence to Global Experts

In the fast-moving world of spine sales, customer relationships go beyond transactions—they’re partnerships built on trust, knowledge, and long-term commitment. A well-implemented Customer Relationship Management (CRM) system can be a game-changer, but only if it’s tailored to the industry's specific needs. Despite its potential, CRM often presents challenges that can limit the … [Read more...] about The Challenges of CRMs in Spine Sales

A Massachusetts federal judge has dismissed the money laundering charges brought against Dr. Kingsley R. Chin in his former capacity as CEO of SpineFrontier Inc.  BOSTON, Dec. 20, 2024 /PRNewswire/ -- A federal judge has dismissed the money laundering charges brought against Dr. Kingsley R. Chin in his former capacity as CEO of SpineFrontier Inc. … [Read more...] about Dr. Kingsley R. Chin: Federal Judge Dismisses Money Laundering Charges in His Former Role as CEO of SpineFrontier Inc.

Ecully, December 18, 2024 – The Spineway Group, a specialist in innovative implants for the treatment of severe spine disorders, announces that it has obtained approvals for its ACIFBOX, VEOS, KAPHORN and TWIN PEAKS ranges in Vietnam. Following this approval, initial orders have been placed, confirming the growing interest in Spineway products in the region. These approvals … [Read more...] about Spineway wins new approvals in Vietnam and registers initial orders

AUSTIN, Dec. 18, 2024 /PRNewswire/ -- DuraStat LLC, a surgical tissue closure company, has launched an exclusive U.S. commercial partnership with Medtronic's Advanced Energy business within the Cranial & Spinal Technologies Operating Unit. The partnership transforms clinical delivery for the company's flagship DuraStat (spine dural repair) and TissueStat … [Read more...] about DuraStat® Launches Commercial Partnership with Medtronic Cranial and Spinal Technologies Business

WEST CHESTER, Pa., Dec. 12, 2024 /PRNewswire/ -- Centinel Spine®, LLC ("the Company"), the leading global medical device company focused exclusively on treating cervical and lumbar spinal disease with the most complete and clinically-proven total disc replacement (TDR) technology platform in the world (prodisc®), today announced the recent release of a landmark study … [Read more...] about Landmark Lumbar Total Disc Replacement Study of Nearly 1,200 Patients Supports Long-term Clinical Success and Durability of Centinel Spine’s prodisc® L System

NGMedical announces completion of patient enrollment for its multi-center one- and two-level trial, designed to support a future PMA-application for MOVE®-C. NONNWEILER, GERMANY, December 10, 2024 /EINPresswire.com/ -- NGMedical GmbH, a medical device manufacturer exclusively focused on creating inno-vative technologies for spinal application, announces completion … [Read more...] about NGMEDICAL Announces Completion of Patient Enrollment in the one- and two-Level MOVE®-C Clinical Trial